Prevendo a sobrevida da fibrose pulmonar idiopática: estamos melhorando? [PDF]
Jornal de Pneumologia, 2003 Collard, Harold R. +1 more
openaire +2 more sources
Idiopathic pulmonary fibrosis in Brazil: challenges for epidemiological characterization and management. [PDF]
J Bras Pneumol, 2017 Baldi BG.
europepmc +1 more source
Transthoracic Echocardiography in Pulmonary Hypertension: Easy Tool, but Caution is Needed! [PDF]
Arq Bras Cardiol, 2023 Yoo HHB.
europepmc +1 more source
Respiratory system parameters in children with low severity cystic fibrosis: is there early involvement in relation to healthy peers? [PDF]
Rev Paul Pediatr, 2023 Ducati GC +3 more
europepmc +1 more source
Inflammation and oxidative stress in the sputum of patients with cystic fibrosis: correlations with lung function, aerobic fitness, and morbidity. [PDF]
Rev Paul PediatrFischer DL +5 more
europepmc +1 more source
Abordagem do doente com fibrose pulmonar idiopática
, 2019 Trabalho Final do Curso de Mestrado Integrado em Medicina, Faculdade de Medicina, Universidade de Lisboa ...
openaire +1 more source
Mortality from idiopathic pulmonary fibrosis: a temporal trend analysis in Brazil, 1979-2014. [PDF]
J Bras Pneumol, 2017 Algranti E +4 more
europepmc +1 more source
Six-minute walk distance and survival time in patients with idiopathic pulmonary fibrosis in Brazil. [PDF]
J Bras Pneumol, 2018 Mancuzo EV, Soares MR, Pereira CAC.
europepmc +1 more source
Mecanismos fisiopatológicos da fibrose pulmonar induzida por fármacos
, 2018 The lungs are a target for a variety of possible toxic substances because of their large contact surface, and the drugs can induce lesions through direct, dose-dependent cytotoxic or immuno-mediated mechanisms, described by Gell and Coombs, for the most part mediated by T cells, giving rise to drug-induced interstitial lung diseases. Pulmonary fibrosis
openaire +1 more source